← 產業報告目錄

Image-guided Navigation Market by Product (Workstation, Software, Navigator), Therapy Area (Neurology, ENT), Type of Navigation (Optical, EM), Care Setting (Interventional Radiology Suite, Surgical), Reference Modality, End User - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-05-01頁數 342報告編號 MD9358

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global image-guided navigation market is projected to grow from USD 2,545.6 million in 2025 to USD 3,912.5 million by 2030, at a CAGR of 9.0%, during the forecast period. Advanced medical systems, such as image-guided navigation, enhance surgical precision by integrating real-time visual guidance through modalities such as CT, MRI, and ultrasound; this integration minimizes complication rates, accelerates recovery periods, and optimizes patient outcomes. The market for these technologies is expanding, propelled by the increasing demand for MIS techniques and the widespread adoption of imaging modalities within operating theaters. Furthermore, the necessity for heightened accuracy in complex surgical interventions, particularly in neurosurgery, orthopedics, and otolaryngology, drives market growth. As healthcare institutions increasingly emphasize safety and operational efficiency, image-guided surgical systems are becoming integral to contemporary surgical practices. By care setting, the surgical segment is projected to grow at the highest CAGR during the forecast period. Between 2025 and 2030, the surgical segment is anticipated to witness the most substantial growth within the image-guided navigation market. This high market growth can be attributed to the ongoing integration of navigation systems into real-time intraoperative workflows. The development of hybrid operating rooms has facilitated a seamless integration of image-guided platforms with surgical microscopes, C-arms, and robotic systems, thereby enhancing the efficiency of intricate procedures such as brain tumor resections and spinal fusions. Moreover, there is a notable increase in demand for intraoperative CT and MRI-compatible navigation systems, particularly in neurosurgery and orthopedics, where dynamic imaging capabilities significantly boost surgical accuracy. Hospitals are increasingly focusing on navigated instrumentation to minimize operative durations and protect critical anatomical structures, especially in ENT and skull base surgeries. This rising procedural demand, coupled with recent regulatory approvals for navigation-integrated surgical tools, has propelled adoption rates specifically within surgical suites rather than in pre-operative or outpatient environments. By type of navigation, the optical navigation segment accounted for the largest market share in 2024. In 2024, the optical navigation segment emerged as the predominant driver of market share within the image-guided navigation landscape, largely owing to its superior line-of-sight accuracy and exceptional spatial resolution, parameters of paramount importance in neurosurgical and spinal procedures. Unlike electromagnetic systems, optical navigation remains impervious to metallic interference from surgical instrumentation, thereby ensuring consistently precise tracking capabilities within intricate operative environments. The incorporation of active infrared markers in optical systems facilitates real-time feedback with sub-millimeter precision, which helps navigate during minimally invasive interventions. The increasing adoption of ceiling-mounted and portable optical tracking systems within hybrid operating suites has significantly enhanced their intraoperative functionality. Moreover, the compatibility of these optical systems with advanced 3D imaging software has solidified their status as the most dependable navigation modality in high-stakes surgical domains. This comprehensive integration underscores the pivotal role of optical navigation in optimizing surgical outcomes. The Asia Pacific region is expected to witness the highest growth rate during the forecast period. The Asia Pacific region is poised for significant growth in the image-guided navigation market from 2025 to 2030, driven by a surge in advanced surgical procedures in countries such as China, India, and South Korea. Strategic government initiatives aimed at enhancing hospital infrastructure, coupled with increased investments in robotic and image-guided surgical technologies, have propelled the demand for these navigation systems. Moreover, the proliferation of specialized neurosurgical and orthopedic centers, alongside the heightened awareness of the benefits of MIS techniques, is facilitating broader adoption of these systems. The local manufacturing and distribution efforts by regional companies have further enhanced the accessibility and affordability of image-guided navigation technologies in emerging markets. This convergence of factors is likely to establish the Asia Pacific as a key player in the advancement of image-guided surgical solutions. Breakdown of supply-side primary interviews: • By Company Type: Tier 1—45%, Tier 2—20%, and Tier 3—35% • By Designation: C-level—35%, Director-level—25%, and Other designations—40% • By Region: North America—40%, Europe—25%, Asia Pacific—20%, Latin America—10%, Middle East & Africa—5% Breakdown of demand-side primary interviews: • By Company Type: Hospitals—60%, Ambulatory Surgery Centers—25%, and Diagnostics Imaging Centers—15% • By Designation: Directors—35%, Vice Presidents—27%, Managers—22%, and Other Designations—16% • By Region: North America—40%, Europe—25%, Asia Pacific—20%, Latin America—10%, Middle East & Africa—5% Research Coverage This report studies the image-guided navigation market based on product type, care setting, therapy area, type of navigation, reference modality type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries. Reasons to Buy the Report The report serves as a valuable resource for both established enterprises and emerging or smaller firms to effectively assess market dynamics. This insight will enable them to capture a larger market share. Organizations that invest in the report can employ one or a combination of the following five strategic approaches. This report provides insights into the following pointers: • Analysis of key drivers (growing adoption of minimally invasive surgical procedures, rising uptake of robotics in surgeries, high government investments, funds, and grants for minimally invasive surgical procedures, increasing applications of image-guided navigation across medical specialties), restraints (High cost of image-guided navigation systems in surgical and interventional procedures, Lack of system accuracy and reliability), opportunities (Rising investments in healthcare AI and big data analytics, Increasing partnerships and collaborations among key players), and challenges (Rising number of product recalls, Limited adoption of image-guided navigation surgeries in emerging economies) influencing the growth of image-guided navigation market. • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the image-guided navigation market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of image-guided navigation procedures across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the image-guided navigation market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the image-guided navigation market.
目錄 Table of Contents
1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 31 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31 1.3.2 INCLUSIONS & EXCLUSIONS 32 1.3.3 YEARS CONSIDERED 33 1.3.4 CURRENCY CONSIDERED 33 1.4 STAKEHOLDERS 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 2.1.1 SECONDARY DATA 35 2.1.1.1 Key sources of secondary data 36 2.1.1.2 Key data from secondary sources 37 2.1.2 PRIMARY DATA 37 2.1.2.1 Key objectives of primary research 38 2.1.2.2 Key data from primary sources 39 2.1.2.3 Insights from primary experts 40 2.2 MARKET SIZE ESTIMATION 42 2.2.1 REVENUE SHARE ANALYSIS (SUPPLY SIDE) 42 2.2.2 TOP-DOWN APPROACH 43 2.2.3 DEMAND-SIDE APPROACH 44 2.2.4 VOLUME DATA ANALYSIS 45 2.3 DATA TRIANGULATION 48 2.4 MARKET SHARE ANALYSIS 48 2.5 STUDY ASSUMPTIONS 49 2.6 RESEARCH LIMITATIONS 49 2.7 RISK ANALYSIS 50 3 EXECUTIVE SUMMARY 51 4 PREMIUM INSIGHTS 56 4.1 IMAGE-GUIDED NAVIGATION MARKET OVERVIEW 56 4.2 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT AND COUNTRY, 2024 57 4.3 IMAGE-GUIDED NAVIGATION MARKET: REGIONAL MIX 57 4.4 IMAGE-GUIDED NAVIGATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 58 4.5 IMAGE-GUIDED NAVIGATION MARKET: EMERGING VS. DEVELOPED MARKETS 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 61 5.2.1 DRIVERS 61 5.2.1.1 Growing adoption of minimally invasive surgical procedures 61 5.2.1.2 Rising uptake of robotics in surgeries 62 5.2.1.3 High government investments, funds, and grants for minimally invasive surgeries 63 5.2.1.4 Increasing applications of image-guided navigation across medical specialties 65 5.2.2 RESTRAINTS 66 5.2.2.1 High cost of image-guided navigation systems in surgical and interventional procedures 66 5.2.2.2 Lack of system accuracy and reliability 66 5.2.3 OPPORTUNITIES 67 5.2.3.1 Rising investments in healthcare AI and big data analytics 67 5.2.3.2 Increasing partnerships and collaborations among large industry players 68 5.2.4 CHALLENGES 69 5.2.4.1 Rising number of product recalls 69 5.2.4.2 Limited adoption of image-guided navigation surgeries in emerging economies 69 5.3 TECHNOLOGY ANALYSIS 70 5.3.1 KEY TECHNOLOGIES 70 5.3.1.1 AI-based image analysis 70 5.3.1.2 Robot-assisted navigation 70 5.3.2 COMPLEMENTARY TECHNOLOGIES 71 5.3.2.1 Patient-specific 3D modelling 71 5.3.2.2 Cloud-based and remote navigation 71 5.4 PORTER’S FIVE FORCES ANALYSIS 71 5.4.1 INTENSITY OF COMPETITIVE RIVALRY 72 5.4.2 BARGAINING POWER OF BUYERS 73 5.4.3 BARGAINING POWER OF SUPPLIERS 73 5.4.4 THREAT OF SUBSTITUTES 73 5.4.5 THREAT OF NEW ENTRANTS 73 5.5 KEY STAKEHOLDERS & BUYING CRITERIA 74 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 74 5.5.2 KEY BUYING CRITERIA 75 5.6 REGULATORY ANALYSIS 75 5.6.1 REGULATORY LANDSCAPE 75 5.6.1.1 North America 75 5.6.1.1.1 US 75 5.6.1.2 Europe 77 5.6.1.3 Asia Pacific 77 5.6.1.3.1 Japan 77 5.6.1.3.2 China 78 5.6.1.3.3 India 79 5.6.1.4 Latin America 79 5.6.1.4.1 Brazil 79 5.6.1.5 Middle East & Africa 79 5.6.1.5.1 UAE 79 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 5.7 PATENT ANALYSIS 81 5.7.1 INSIGHTS ON PATENT PUBLICATION TRENDS (TOP APPLICANTS/JURISDICTION) 81 5.7.2 LIST OF MAJOR PATENTS, 2023–2025 83 5.8 TRADE ANALYSIS 84 5.8.1 IMPORT DATA FOR HS CODE 901820, 2020–2024 84 5.8.2 EXPORT DATA FOR HS CODE 901820, 2020–2024 85 5.9 PRICING ANALYSIS 86 5.9.1 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY KEY PLAYER, 2022–2024 86 5.9.2 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY REGION, 2022–2024 87 5.10 KEY CONFERENCES & EVENTS, 2025–2026 87 5.11 UNMET NEEDS/END-USER EXPECTATIONS 88 5.12 VALUE CHAIN ANALYSIS 89 5.13 SUPPLY CHAIN ANALYSIS 90 5.14 ECOSYSTEM ANALYSIS 91 5.15 CASE STUDY ANALYSIS 92 5.15.1 BRAINLAB'S SMART NAVIGATION SYSTEM TO IMPROVE BRAIN TUMOR SURGERY 92 5.15.2 ZIMMER BIOMET’S ROBOTIC NAVIGATION TO ASSIST MINIMALLY INVASIVE JOINT REPLACEMENT SURGERIES 92 5.15.3 MEDTRONIC'S PRECISION NAVIGATION SYSTEM TO CONDUCT ADVANCED SPINE SURGERIES 93 5.16 ADJACENT MARKET ANALYSIS 93 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 94 5.18 INVESTMENT & FUNDING SCENARIO 94 5.19 IMPACT OF AI/GEN AI ON IMAGE-GUIDED NAVIGATION MARKET 95 5.20 IMPACT OF 2025 US TARIFF ON IMAGE-GUIDED NAVIGATION MARKET 95 5.20.1 INTRODUCTION 95 5.20.2 KEY TARIFF RATES 96 5.20.3 PRICE IMPACT ANALYSIS 97   5.20.4 IMPACT ON COUNTRY/REGION 97 5.20.4.1 North America 97 5.20.4.1.1 US 97 5.20.4.2 Europe 97 5.20.4.3 Asia Pacific 98 5.20.5 IMPACT ON END-USE INDUSTRIES 98 5.20.5.1 Hospitals 98 5.20.5.2 Ambulatory surgery centers 98 5.20.5.3 Diagnostic imaging centers 98 6 IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT 99 6.1 INTRODUCTION 100 6.2 WORKSTATIONS & SOFTWARE 100 6.2.1 DEMAND FOR ADVANCED SURGICAL PLANNING TOOLS AND REAL-TIME INTRAOPERATIVE NAVIGATION SYSTEMS TO DRIVE MARKET 100 6.3 NAVIGATORS 103 6.3.1 PREVALENCE OF COMPLEX MEDICAL CONDITIONS REQUIRING PRECISE SURGICAL INTERVENTIONS TO AUGMENT MARKET GROWTH 103 6.4 CONSUMABLES 105 6.4.1 INCREASING POPULARITY OF MINIMALLY INVASIVE SURGERIES TO BOOST DEMAND FOR CONSUMABLES 105 7 IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING 107 7.1 INTRODUCTION 108 7.2 INTERVENTIONAL RADIOLOGY SUITE 108 7.2.1 GROWING INTEGRATION OF HYBRID OPERATING ROOMS WITH ADVANCED IMAGING CAPABILITIES TO SUPPORT MARKET GROWTH 108 7.3 SURGICAL 110 7.3.1 SURGICAL NAVIGATION SYSTEMS TO MINIMIZE TISSUE DAMAGE AND ENABLE MORE TARGETED INTERVENTIONS 110 7.4 OTHER CARE SETTINGS 111 8 IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA 113 8.1 INTRODUCTION 114 8.2 ONCOLOGY 115 8.2.1 INCREASING INCIDENCE OF CANCER TO DRIVE MARKET 115 8.3 NEUROLOGY 117 8.3.1 NEED FOR HIGH PRECISION IN BRAIN AND SPINAL SURGERIES TO SUPPORT MARKET GROWTH 117 8.4 ENT 119 8.4.1 INCREASING INCIDENCE OF COMPLEX ENT-RELATED INJURIES AND DISEASES TO FAVOR MARKET GROWTH 119 8.5 PULMONARY 121 8.5.1 HIGH BURDEN OF LUNG CANCER TO SPUR MARKET GROWTH 121 8.6 GASTROENTEROLOGY 123 8.6.1 INCREASED PREVALENCE OF COLORECTAL CANCER TO AUGMENT MARKET GROWTH 123 8.7 MUSCULOSKELETAL 125 8.7.1 RISING MUSCULOSKELETAL SURGICAL VOLUME TO FAVOR MARKET GROWTH 125 8.8 DENTAL 127 8.8.1 IMAGE-GUIDED DENTAL NAVIGATION SYSTEMS TO FACILITATE MINIMALLY-INVASIVE PROCEDURES AND ENHANCE PATIENT RECOVERY 127 8.9 CARDIOVASCULAR 129 8.9.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES TO AID MARKET GROWTH 129 8.10 OTHER THERAPY AREAS 131 9 IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION 133 9.1 INTRODUCTION 134 9.2 OPTICAL NAVIGATION 134 9.2.1 HIGH PRECISION AND SEAMLESS INTEGRATION WITH IMAGING MODALITIES TO AID ADOPTION IN SURGICAL APPLICATIONS 134 9.3 ELECTROMAGNETIC NAVIGATION 137 9.3.1 TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF HIGH-PRECISION GUIDANCE TO PROPEL MARKET GROWTH 137 9.4 ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION 139 9.4.1 GROWING REQUIREMENT FOR ADVANCED VISUALIZATION AND PRECISION IN COMPLEX SURGERIES TO DRIVE MARKET 139 10 IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE 141 10.1 INTRODUCTION 142 10.2 CT-BASED REFERENCE 142 10.2.1 WIDESPREAD CLINICAL USE AND DIAGNOSTIC ACCURACY OF CT SCANS TO PROPEL MARKET GROWTH 142 10.3 FLUOROSCOPY-BASED REFERENCE 144 10.3.1 ADVANCEMENTS IN FLUOROSCOPY TECHNOLOGY FOR COMPLEX SURGERIES TO AUGMENT MARKET GROWTH 144 10.4 MRI-BASED REFERENCE 146 10.4.1 SUPERIOR IMAGING CAPABILITIES TO ACCELERATE MARKET GROWTH 146 10.5 ULTRASOUND-BASED REFERENCE 148 10.5.1 TECHNOLOGICAL ADVANCEMENTS TO FUEL UPTAKE OF ULTRASOUND-BASED REFERENCE IN POINT-OF-CARE APPLICATIONS 148 10.6 OTHER REFERENCE MODALITY TYPES 150   11 IMAGE-GUIDED NAVIGATION MARKET, BY END USER 151 11.1 INTRODUCTION 152 11.2 HOSPITALS 152 11.2.1 BETTER RESOURCE AND COST MANAGEMENT TO FAVOR MARKET GROWTH 152 11.3 AMBULATORY SURGERY CENTERS 154 11.3.1 COST-EFFECTIVENESS AND IMPROVED PATIENT CONVENIENCE TO FAVOR MARKET GROWTH 154 11.4 DIAGNOSTIC IMAGING CENTERS 156 11.4.1 DIAGNOSTIC IMAGING CENTERS TO INTEGRATE IMAGE-GUIDED NAVIGATION SYSTEMS FOR IMPROVED PROCEDURAL OUTCOMES 156 12 IMAGE-GUIDED NAVIGATION MARKET, BY REGION 158 12.1 INTRODUCTION 159 12.2 NORTH AMERICA 160 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 160 12.2.2 US 165 12.2.2.1 US to dominate North American image-guided navigation market during forecast period 165 12.2.3 CANADA 168 12.2.3.1 High government investments in digital research infrastructure to propel market growth 168 12.3 EUROPE 172 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 172 12.3.2 GERMANY 176 12.3.2.1 Strong healthcare infrastructure and demand for advanced surgical technologies to augment market growth 176 12.3.3 UK 180 12.3.3.1 High burden of complex diseases and well-developed public healthcare system to fuel market growth 180 12.3.4 FRANCE 183 12.3.4.1 Increased demand for minimally invasive surgeries and favorable government investments in digital health to aid market growth 183 12.3.5 ITALY 187 12.3.5.1 Strong network of public and private hospitals and high prevalence of complex diseases to propel market growth 187 12.3.6 SPAIN 190 12.3.6.1 Advancements in healthcare infrastructure to boost market growth 190 12.3.7 REST OF EUROPE 193 12.4 ASIA PACIFIC 197 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 197 12.4.2 CHINA 202 12.4.2.1 Large patient population and favorable government initiatives to fuel adoption during surgeries 202   12.4.3 JAPAN 206 12.4.3.1 High geriatric population and universal reimbursement policy for standardized healthcare services to drive market 206 12.4.4 INDIA 209 12.4.4.1 Availability of skilled medical professionals to augment market growth 209 12.4.5 SOUTH KOREA 213 12.4.5.1 Advanced healthcare infrastructure and increased popularity of robot-assisted surgeries to fuel market growth 213 12.4.6 AUSTRALIA 216 12.4.6.1 Rising burden of neurological and spinal disorders to fuel uptake of image-guided navigation products 216 12.4.7 REST OF ASIA PACIFIC 220 12.5 LATIN AMERICA 223 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 223 12.5.2 BRAZIL 227 12.5.2.1 Increased government healthcare budget and favorable regulatory policies to support market growth 227 12.5.3 MEXICO 230 12.5.3.1 Nearshoring of medical device manufacturing to propel market growth 230 12.5.4 ARGENTINA 234 12.5.4.1 High government healthcare investments and increased prevalence of chronic diseases to drive market 234 12.5.5 REST OF LATIN AMERICA 237 12.6 MIDDLE EAST & AFRICA 240 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 241 12.6.2 GCC COUNTRIES 244 12.6.2.1 Increased government investments in medical sector to spur market growth 244 12.6.3 REST OF MIDDLE EAST & AFRICA 247 13 COMPETITIVE LANDSCAPE 251 13.1 INTRODUCTION 251 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 251 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET 251 13.3 REVENUE ANALYSIS, 2020–2024 253 13.4 MARKET SHARE ANALYSIS, 2024 254 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 257 13.5.1 STARS 257 13.5.2 EMERGING LEADERS 257 13.5.3 PERVASIVE PLAYERS 257 13.5.4 PARTICIPANTS 257   13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 259 13.5.5.1 Company footprint 259 13.5.5.2 Region footprint 260 13.5.5.3 Product footprint 261 13.5.5.4 Care setting footprint 261 13.5.5.5 Therapy area footprint 262 13.5.5.6 Type of navigation footprint 263 13.5.5.7 Reference modality type footprint 264 13.6 COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2024 265 13.6.1 PROGRESSIVE COMPANIES 265 13.6.2 RESPONSIVE COMPANIES 265 13.6.3 DYNAMIC COMPANIES 265 13.6.4 STARTING BLOCKS 265 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 267 13.6.5.1 Detailed list of key startups/SME players 267 13.6.5.2 Competitive benchmarking of startups/SME players 268 13.7 COMPANY VALUATION & FINANCIAL METRICS 269 13.7.1 FINANCIAL METRICS 269 13.7.2 COMPANY VALUATION 269 13.8 BRAND/PRODUCT COMPARISON 270 13.9 R&D ASSESSMENT OF KEY PLAYERS 271 13.10 COMPETITIVE SCENARIO 271 13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 271 13.10.2 DEALS 272 13.10.3 EXPANSIONS 274 14 COMPANY PROFILES 275 14.1 KEY PLAYERS 275 14.1.1 MEDTRONIC 275 14.1.1.1 Business overview 275 14.1.1.2 Products/Services/Solutions offered 276 14.1.1.3 Recent developments 277 14.1.1.3.1 Product launches 277 14.1.1.3.2 Deals 278 14.1.1.3.3 Expansions 278 14.1.1.4 MnM view 279 14.1.1.4.1 Key strengths 279 14.1.1.4.2 Strategic choices 279 14.1.1.4.3 Weaknesses & competitive threats 279   14.1.2 BRAINLAB AG 280 14.1.2.1 Business overview 280 14.1.2.2 Products/Services/Solutions offered 280 14.1.2.3 Recent developments 281 14.1.2.3.1 Product approvals 281 14.1.2.3.2 Deals 282 14.1.2.4 MnM view 282 14.1.2.4.1 Key strengths 282 14.1.2.4.2 Strategic choices 283 14.1.2.4.3 Weaknesses & competitive threats 283 14.1.3 STRYKER 284 14.1.3.1 Business overview 284 14.1.3.2 Products/Services/Solutions offered 285 14.1.3.3 Recent developments 286 14.1.3.3.1 Product approvals 286 14.1.3.4 MnM view 287 14.1.3.4.1 Key strengths 287 14.1.3.4.2 Strategic choices 287 14.1.3.4.3 Weaknesses & competitive threats 287 14.1.4 B. BRAUN SE 288 14.1.4.1 Business overview 288 14.1.4.2 Products/Services/Solutions offered 289 14.1.4.3 Recent developments 290 14.1.4.3.1 Deals 290 14.1.4.4 MnM view 291 14.1.4.4.1 Right to win 291 14.1.4.4.2 Strategic choices 291 14.1.4.4.3 Weaknesses & competitive threats 291 14.1.5 KONINKLIJKE PHILIPS N.V. 292 14.1.5.1 Business overview 292 14.1.5.2 Products/Services/Solutions offered 293 14.1.5.3 Recent developments 294 14.1.5.3.1 Product launches 294 14.1.5.4 MnM view 295 14.1.5.4.1 Key strengths 295 14.1.5.4.2 Strategic choices 295 14.1.5.4.3 Weaknesses & competitive threats 295   14.1.6 GE HEALTHCARE 296 14.1.6.1 Business overview 296 14.1.6.2 Products/Services/Solutions offered 297 14.1.6.3 Recent developments 298 14.1.6.3.1 Product approvals 298 14.1.6.3.2 Deals 298 14.1.7 OLYMPUS CORPORATION 299 14.1.7.1 Business overview 299 14.1.7.2 Products/Services/Solutions offered 300 14.1.7.3 Recent developments 301 14.1.7.3.1 Deals 301 14.1.8 SMITH+NEPHEW 302 14.1.8.1 Business overview 302 14.1.8.2 Products/Services/Solutions offered 303 14.1.8.3 Recent development 303 14.1.8.3.1 Deals 303 14.1.9 JOHNSON & JOHNSON SERVICES, INC. 304 14.1.9.1 Business overview 304 14.1.9.2 Products/Services/Solutions offered 305 14.1.9.3 Recent development 306 14.1.9.3.1 Deals 306 14.1.10 GLOBUS MEDICAL (NUVASIVE) 307 14.1.10.1 Business overview 307 14.1.10.2 Products/Services/Solutions offered 308 14.1.10.3 Recent development 309 14.1.10.3.1 Deals 309 14.1.11 STEREOTAXIS, INC. 310 14.1.11.1 Business overview 310 14.1.11.2 Products/Services/Solutions offered 311 14.1.11.3 Recent developments 311 14.1.11.3.1 Product approvals 311 14.1.11.3.2 Deals 312 14.1.12 ORTHOFIX MEDICAL INC. 313 14.1.12.1 Business overview 313 14.1.12.2 Products/Services/Solutions offered 314 14.1.12.3 Recent developments 315 14.1.12.3.1 Deals 315 14.1.13 INTEGRA LIFESCIENCES CORPORATION 316 14.1.13.1 Business overview 316 14.1.13.2 Products/Services/Solutions offered 317 14.1.13.3 Recent developments 318 14.1.13.3.1 Deals 318 14.1.14 ZIMMER BIOMET 319 14.1.14.1 Business overview 319 14.1.14.2 Products/Services/Solutions offered 320 14.1.14.3 Recent developments 321 14.1.14.3.1 Deals 321 14.1.15 INTUITIVE SURGICAL 322 14.1.15.1 Business overview 322 14.1.15.2 Products/Services/Solutions offered 323 14.1.15.3 Recent developments 323 14.1.15.3.1 Other developments 323 14.2 OTHER PLAYERS 324 14.2.1 KARL STORZ 324 14.2.2 FIAGON GMBH 325 14.2.3 ZETA SURGICAL INC. 326 14.2.4 BRAIN NAVI BIOTECHNOLOGY CO., LTD. 327 14.2.5 IMAGE NAVIGATION, LTD. 328 14.2.6 HAPPY RELIABLE SURGERIES PVT. LTD. 329 14.2.7 RXOOM HEALTHCARE PVT. LTD. 330 14.2.8 CLARONAV 331 14.2.9 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD. 331 14.2.10 ZIEHM IMAGING GMBH 332 15 APPENDIX 333 15.1 DISCUSSION GUIDE 333 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 338 15.3 CUSTOMIZATION OPTIONS 340 15.4 RELATED REPORTS 340 15.5 AUTHOR DETAILS 341
圖表清單 List of Tables & Figures
TABLE 1 IMAGE-GUIDED NAVIGATION MARKET: INCLUSIONS & EXCLUSIONS 32 TABLE 2 STANDARD CURRENCY EXCHANGE RATES, 2021–2024 (USD) 33 TABLE 3 IMAGE-GUIDED NAVIGATION MARKET: STUDY ASSUMPTIONS 49 TABLE 4 IMAGE-GUIDED NAVIGATION MARKET: RISK ANALYSIS 50 TABLE 5 MAJOR FUNDING BY GOVERNMENT BODIES, 2021–2024 64 TABLE 6 PROJECTS FUNDED BY NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING, 2024 64 TABLE 7 IMAGE-GUIDED NAVIGATION MARKET: PORTER’S FIVE FORCES 71 TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 74 TABLE 9 KEY BUYING CRITERIA FOR IMAGE-GUIDED NAVIGATION SYSTEMS, BY END USER 75 TABLE 10 US FDA: CLASSIFICATION OF MEDICAL DEVICES 76 TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76 TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA) 78 TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES 78 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 17 IMAGE-GUIDED NAVIGATION MARKET: LIST OF MAJOR PATENTS, JANUARY 2023–MARCH 2025 83 TABLE 18 IMPORT DATA FOR HS CODE 901820, BY COUNTRY, 2020–2024 (USD THOUSAND) 85 TABLE 19 EXPORT DATA FOR HS CODE 901820, BY COUNTRY, 2020–2024 (USD THOUSAND) 85 TABLE 20 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 86 TABLE 21 AVERAGE SELLING PRICE TREND OF IMAGE-GUIDED NAVIGATION PRODUCTS, BY REGION, 2022–2024 (USD) 87 TABLE 22 IMAGE-GUIDED NAVIGATION MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026 87 TABLE 23 IMAGE-GUIDED NAVIGATION MARKET: UNMET NEEDS/END-USER EXPECTATIONS 88 TABLE 24 CASE STUDY 1: BRAINLAB'S SMART NAVIGATION SYSTEM TO IMPROVE BRAIN TUMOR SURGERY 92 TABLE 25 CASE STUDY 2: ZIMMER BIOMET’S ROBOTIC NAVIGATION TO ASSIST MINIMALLY INVASIVE JOINT REPLACEMENT SURGERIES 92 TABLE 26 CASE STUDY 3: MEDTRONIC'S PRECISION NAVIGATION SYSTEM TO CONDUCT ADVANCED SPINE SURGERIES 93 TABLE 27 IMAGE-GUIDED NAVIGATION MARKET: IMPACT OF AI/GEN AI 95 TABLE 28 US: ADJUSTED RECIPROCAL TARIFF RATES 96 TABLE 29 IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 100 TABLE 30 KEY WORKSTATIONS & SOFTWARE AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 101 TABLE 31 IMAGE-GUIDED NAVIGATION MARKET FOR WORKSTATIONS & SOFTWARE, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 32 KEY NAVIGATORS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 103 TABLE 33 IMAGE-GUIDED NAVIGATION MARKET FOR NAVIGATORS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 34 KEY CONSUMABLES AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 105 TABLE 35 IMAGE-GUIDED NAVIGATION MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 36 IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 108 TABLE 37 IMAGE-GUIDED NAVIGATION MARKET FOR INTERVENTIONAL RADIOLOGY SUITE, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 38 IMAGE-GUIDED NAVIGATION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 39 IMAGE-GUIDED NAVIGATION MARKET FOR OTHER CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 40 IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 114 TABLE 41 KEY ONCOLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 115 TABLE 42 IMAGE-GUIDED NAVIGATION MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 43 KEY NEUROLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 117 TABLE 44 IMAGE-GUIDED NAVIGATION MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 45 KEY ENT PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 119 TABLE 46 IMAGE-GUIDED NAVIGATION MARKET FOR ENT, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 47 KEY PULMONARY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 121 TABLE 48 IMAGE-GUIDED NAVIGATION MARKET FOR PULMONARY, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 49 KEY GASTROENTEROLOGY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 123 TABLE 50 IMAGE-GUIDED NAVIGATION MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 51 KEY MUSCULOSKELETAL PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 125 TABLE 52 IMAGE-GUIDED NAVIGATION MARKET FOR MUSCULOSKELETAL, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 53 KEY DENTAL PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 127 TABLE 54 IMAGE-GUIDED NAVIGATION MARKET FOR DENTAL, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 55 KEY CARDIOVASCULAR PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 129 TABLE 56 IMAGE-GUIDED NAVIGATION MARKET FOR CARDIOVASCULAR, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 57 KEY OTHER THERAPY PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 131 TABLE 58 IMAGE-GUIDED NAVIGATION MARKET FOR OTHER THERAPY AREAS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 59 IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 134 TABLE 60 KEY OPTICAL NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 135 TABLE 61 IMAGE-GUIDED OPTICAL NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 62 KEY ELECTROMAGNETIC NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 137 TABLE 63 IMAGE-GUIDED ELECTROMAGNETIC NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 64 KEY ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION PRODUCTS AVAILABLE IN IMAGE-GUIDED NAVIGATION MARKET 139 TABLE 65 IMAGE-GUIDED ROBOTIC-ASSISTED TRACKING AND AUGMENTED REALITY & MIXED REALITY NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 66 IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 142 TABLE 67 IMAGE-GUIDED NAVIGATION MARKET FOR CT-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 68 IMAGE-GUIDED NAVIGATION MARKET FOR FLUOROSCOPY-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 69 IMAGE-GUIDED NAVIGATION MARKET FOR MRI-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 70 IMAGE-GUIDED NAVIGATION MARKET FOR ULTRASOUND-BASED REFERENCE, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 71 IMAGE-GUIDED NAVIGATION MARKET FOR OTHER REFERENCE MODALITY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 72 IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 73 IMAGE-GUIDED NAVIGATION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 74 IMAGE-GUIDED NAVIGATION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 75 IMAGE-GUIDED NAVIGATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 76 IMAGE-GUIDED NAVIGATION MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 77 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 78 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 79 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD) 162 TABLE 80 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 163 TABLE 81 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 163 TABLE 82 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 164 TABLE 83 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 164 TABLE 84 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 85 US: KEY MACROINDICATORS 166 TABLE 86 US: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 166 TABLE 87 US: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 166 TABLE 88 US: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 167 TABLE 89 US: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 167 TABLE 90 US: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 168 TABLE 91 US: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 92 CANADA: KEY MACROINDICATORS 169 TABLE 93 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 94 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 170 TABLE 95 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 170 TABLE 96 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 171 TABLE 97 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 171 TABLE 98 CANADA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 99 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 100 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 101 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD) 174 TABLE 102 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 174 TABLE 103 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 175 TABLE 104 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 175 TABLE 105 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 176 TABLE 106 EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 107 GERMANY: KEY MACROINDICATORS 177 TABLE 108 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 109 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 178 TABLE 110 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 178 TABLE 111 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 179 TABLE 112 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 179 TABLE 113 GERMANY: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 180 TABLE 114 UK: KEY MACROINDICATORS 181 TABLE 115 UK: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 181 TABLE 116 UK: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 181 TABLE 117 UK: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 182 TABLE 118 UK: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 182 TABLE 119 UK: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 183 TABLE 120 UK: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 121 FRANCE: KEY MACROINDICATORS 184 TABLE 122 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184 TABLE 123 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 185 TABLE 124 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 185 TABLE 125 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 186 TABLE 126 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 186 TABLE 127 FRANCE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 128 ITALY: KEY MACROINDICATORS 187 TABLE 129 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 130 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 188 TABLE 131 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 189 TABLE 132 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 189 TABLE 133 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 190 TABLE 134 ITALY: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 135 SPAIN: KEY MACROINDICATORS 191 TABLE 136 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 191 TABLE 137 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 191 TABLE 138 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 192 TABLE 139 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 192 TABLE 140 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 193 TABLE 141 SPAIN: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 142 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 194 TABLE 143 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 194 TABLE 144 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 195 TABLE 145 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 195 TABLE 146 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 196 TABLE 147 REST OF EUROPE: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 148 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 149 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 150 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD) 200 TABLE 151 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 200 TABLE 152 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 201 TABLE 153 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 201 TABLE 154 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 202 TABLE 155 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 156 CHINA: KEY MACROINDICATORS 203 TABLE 157 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 203 TABLE 158 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 204 TABLE 159 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 204 TABLE 160 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 205 TABLE 161 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 205 TABLE 162 CHINA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 163 JAPAN: KEY MACROINDICATORS 206 TABLE 164 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 207 TABLE 165 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 207 TABLE 166 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 208 TABLE 167 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 208 TABLE 168 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 209 TABLE 169 JAPAN: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 170 INDIA: KEY MACROINDICATORS 210 TABLE 171 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210 TABLE 172 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 211 TABLE 173 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 211 TABLE 174 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 212 TABLE 175 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 212 TABLE 176 INDIA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 177 SOUTH KOREA: KEY MACROINDICATORS 213 TABLE 178 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 214 TABLE 179 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 214 TABLE 180 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 215 TABLE 181 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 215 TABLE 182 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 216 TABLE 183 SOUTH KOREA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 216 TABLE 184 AUSTRALIA: KEY MACROINDICATORS 217 TABLE 185 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 217 TABLE 186 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 218 TABLE 187 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 218 TABLE 188 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 219 TABLE 189 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 219 TABLE 190 AUSTRALIA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 191 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220 TABLE 192 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 221 TABLE 193 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 221 TABLE 194 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 222 TABLE 195 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 222 TABLE 196 REST OF ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 197 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 198 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 224 TABLE 199 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD) 224 TABLE 200 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 225 TABLE 201 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 225 TABLE 202 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 226 TABLE 203 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 226 TABLE 204 LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 227 TABLE 205 BRAZIL: KEY MACROINDICATORS 227 TABLE 206 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 228 TABLE 207 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 228 TABLE 208 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 229 TABLE 209 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 229 TABLE 210 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 230 TABLE 211 BRAZIL: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 212 MEXICO: KEY MACROINDICATORS 231 TABLE 213 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 231 TABLE 214 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 232 TABLE 215 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 232 TABLE 216 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 233 TABLE 217 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 233 TABLE 218 MEXICO: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 219 ARGENTINA: KEY MACROINDICATORS 234 TABLE 220 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 235 TABLE 221 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 235 TABLE 222 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 236 TABLE 223 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 236 TABLE 224 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 237 TABLE 225 ARGENTINA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 237 TABLE 226 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 238 TABLE 227 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 238 TABLE 228 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 239 TABLE 229 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 239 TABLE 230 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 240 TABLE 231 REST OF LATIN AMERICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 240 TABLE 232 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY REGION, 2023–2030 (USD MILLION) 241 TABLE 233 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 241 TABLE 234 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (UNITS SOLD) 242 TABLE 235 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 242 TABLE 236 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 243 TABLE 237 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 243 TABLE 238 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 244 TABLE 239 MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 244 TABLE 240 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 245 TABLE 241 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 245 TABLE 242 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 246 TABLE 243 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 246 TABLE 244 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 247 TABLE 245 GCC COUNTRIES: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 247 TABLE 246 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 248 TABLE 247 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2023–2030 (USD MILLION) 248 TABLE 248 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2023–2030 (USD MILLION) 249 TABLE 249 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2023–2030 (USD MILLION) 249 TABLE 250 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2023–2030 (USD MILLION) 250 TABLE 251 REST OF MIDDLE EAST & AFRICA: IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2023–2030 (USD MILLION) 250 TABLE 252 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET 251 TABLE 253 IMAGE-GUIDED NAVIGATION MARKET: DEGREE OF COMPETITION 255 TABLE 254 IMAGE-GUIDED NAVIGATION MARKET: REGION FOOTPRINT 260 TABLE 255 IMAGE-GUIDED NAVIGATION MARKET: PRODUCT FOOTPRINT 261 TABLE 256 IMAGE-GUIDED NAVIGATION MARKET: CARE SETTING FOOTPRINT 261 TABLE 257 IMAGE-GUIDED NAVIGATION MARKET: THERAPY AREA FOOTPRINT 262 TABLE 258 IMAGE-GUIDED NAVIGATION MARKET: TYPE OF NAVIGATION FOOTPRINT 263 TABLE 259 IMAGE-GUIDED NAVIGATION MARKET: REFERENCE MODALITY TYPE FOOTPRINT 264 TABLE 260 IMAGE-GUIDED NAVIGATION MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 267 TABLE 261 IMAGE-GUIDED NAVIGATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS 268 TABLE 262 IMAGE-GUIDED NAVIGATION MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022–MARCH 2025 271 TABLE 263 IMAGE-GUIDED NAVIGATION MARKET: DEALS, JANUARY 2022–MARCH 2025 272 TABLE 264 IMAGE-GUIDED NAVIGATION MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025 274 TABLE 265 MEDTRONIC: COMPANY OVERVIEW 275 TABLE 266 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 276 TABLE 267 MEDTRONIC: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 277 TABLE 268 MEDTRONIC: DEALS, JANUARY 2022–MARCH 2025 278 TABLE 269 MEDTRONIC: EXPANSIONS: JANUARY 2022–MARCH 2025 278 TABLE 270 BRAINLAB AG: COMPANY OVERVIEW 280 TABLE 271 BRAINLAB AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 280 TABLE 272 BRAINLAB AG: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 281 TABLE 273 BRAINLAB AG: DEALS, JANUARY 2022–MARCH 2025 282 TABLE 274 STRYKER: COMPANY OVERVIEW 284 TABLE 275 STRYKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 285   TABLE 276 STRYKER: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 286 TABLE 277 B. BRAUN SE: COMPANY OVERVIEW 288 TABLE 278 B. BRAUN SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 289 TABLE 279 B. BRAUN SE.: DEALS, JANUARY 2022–MARCH 2025 290 TABLE 280 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 292 TABLE 281 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 293 TABLE 282 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 294 TABLE 283 GE HEALTHCARE: COMPANY OVERVIEW 296 TABLE 284 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 297 TABLE 285 GE HEALTHCARE: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 298 TABLE 286 GE HEALTHCARE: DEALS, JANUARY 2022–MARCH 2025 298 TABLE 287 OLYMPUS CORPORATION: COMPANY OVERVIEW 299 TABLE 288 OLYMPUS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 300 TABLE 289 OLYMPUS CORPORATION: DEALS, JANUARY 2022–MARCH 2025 301 TABLE 290 SMITH+NEPHEW: COMPANY OVERVIEW 302 TABLE 291 SMITH+NEPHEW: PRODUCTS/SERVICES/SOLUTIONS OFFERED 303 TABLE 292 SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025 303 TABLE 293 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 304 TABLE 294 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 305 TABLE 295 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–MARCH 2025 306 TABLE 296 GLOBUS MEDICAL (NUVASIVE): COMPANY OVERVIEW 307 TABLE 297 GLOBUS MEDICAL (NUVASIVE): PRODUCTS/SERVICES/SOLUTIONS OFFERED 308 TABLE 298 GLOBUS MEDICAL (NUVASIVE): DEALS, JANUARY 2022–MARCH 2025 309 TABLE 299 STEREOTAXIS, INC.: COMPANY OVERVIEW 310 TABLE 300 STEREOTAXIS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 311 TABLE 301 STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 311 TABLE 302 STEREOTAXIS, INC.: DEALS, JANUARY 2022–MARCH 2025 312 TABLE 303 ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW 313 TABLE 304 ORTHOFIX MEDICAL INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 314 TABLE 305 ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2022–MARCH 2025 315 TABLE 306 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 316 TABLE 307 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 317 TABLE 308 INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2022–MARCH 2025 318 TABLE 309 ZIMMER BIOMET: COMPANY OVERVIEW 319 TABLE 310 ZIMMER BIOMET: PRODUCTS/SERVICES/SOLUTIONS OFFERED 320 TABLE 311 ZIMMER BIOMET: DEALS, JANUARY 2022–MARCH 2025 321 TABLE 312 INTUITIVE SURGICAL: COMPANY OVERVIEW 322 TABLE 313 INTUITIVE SURGICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 323 TABLE 314 INTUITIVE SURGICAL: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 323   TABLE 315 KARL STORZ: COMPANY OVERVIEW 324 TABLE 316 FIAGON GMBH: COMPANY OVERVIEW 325 TABLE 317 ZETA SURGICAL INC.: COMPANY OVERVIEW 326 TABLE 318 BRAIN NAVI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 327 TABLE 319 IMAGE NAVIGATION, LTD.: COMPANY OVERVIEW 328 TABLE 320 HAPPY RELIABLE SURGERIES PVT. LTD.: COMPANY OVERVIEW 329 TABLE 321 RXOOM HEALTHCARE PVT. LTD.: COMPANY OVERVIEW 330 TABLE 322 CLARONAV: COMPANY OVERVIEW 331 TABLE 323 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.: COMPANY OVERVIEW 331 TABLE 324 ZIEHM IMAGING GMBH: COMPANY OVERVIEW 332 FIGURE 1 IMAGE-GUIDED NAVIGATION MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31 FIGURE 2 IMAGE-GUIDED NAVIGATION MARKET: YEARS CONSIDERED 33 FIGURE 3 IMAGE-GUIDED NAVIGATION MARKET: RESEARCH DESIGN 35 FIGURE 4 IMAGE-GUIDED NAVIGATION MARKET: KEY DATA FROM SECONDARY SOURCES 37 FIGURE 5 IMAGE-GUIDED NAVIGATION MARKET: KEY PRIMARY SOURCES 38 FIGURE 6 IMAGE-GUIDED NAVIGATION MARKET: KEY DATA FROM PRIMARY SOURCES 39 FIGURE 7 IMAGE-GUIDED NAVIGATION MARKET: KEY INSIGHTS FROM PRIMARIES 40 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND OTHER PARTICIPANTS 40 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41 FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 41 FIGURE 11 IMAGE-GUIDED NAVIGATION MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS) 42 FIGURE 12 IMAGE-GUIDED NAVIGATION MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR MEDTRONIC (2024) 43 FIGURE 13 IMAGE-GUIDED NAVIGATION MARKET: TOP-DOWN APPROACH 43 FIGURE 14 IMAGE-GUIDED NAVIGATION MARKET: SUPPLY-SIDE ANALYSIS (2024) 46 FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN IMAGE-GUIDED NAVIGATION MARKET 47 FIGURE 16 IMAGE-GUIDED NAVIGATION MARKET: CAGR PROJECTIONS 47 FIGURE 17 IMAGE-GUIDED NAVIGATION MARKET: DATA TRIANGULATION 48 FIGURE 18 IMAGE-GUIDED NAVIGATION MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 51 FIGURE 19 IMAGE-GUIDED NAVIGATION MARKET, BY CARE SETTING, 2025 VS. 2030 (USD MILLION) 52 FIGURE 20 IMAGE-GUIDED NAVIGATION MARKET, BY THERAPY AREA, 2025 VS. 2030 (USD MILLION) 52 FIGURE 21 IMAGE-GUIDED NAVIGATION MARKET, BY TYPE OF NAVIGATION, 2025 VS. 2030 (USD MILLION) 53 FIGURE 22 IMAGE-GUIDED NAVIGATION MARKET, BY REFERENCE MODALITY TYPE, 2025 VS. 2030 (USD MILLION) 54 FIGURE 23 IMAGE-GUIDED NAVIGATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54 FIGURE 24 IMAGE-GUIDED NAVIGATION MARKET: REGIONAL SNAPSHOT 55 FIGURE 25 INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING ADOPTION OF MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET 56 FIGURE 26 US AND WORKSTATIONS & SOFTWARE SEGMENT COMMANDED LARGEST NORTH AMERICAN MARKET SHARE IN 2024 57 FIGURE 27 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 57 FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 58   FIGURE 29 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 59 FIGURE 30 IMAGE-GUIDED NAVIGATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61 FIGURE 31 NUMBER OF MINIMALLY INVASIVE SURGICAL PROCEDURES IN US (2018–2023) 62 FIGURE 32 IMAGE-GUIDED NAVIGATION MARKET: PORTER’S FIVE FORCES ANALYSIS 72 FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 74 FIGURE 34 KEY BUYING CRITERIA FOR IMAGE-GUIDED NAVIGATION SYSTEMS, BY END USER 75 FIGURE 35 IMAGE-GUIDED NAVIGATION MARKET: PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2014–MARCH 2025) 82 FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR IMAGE-GUIDED NAVIGATION PATENTS (JANUARY 2014–MARCH 2025) 83 FIGURE 37 IMAGE-GUIDED NAVIGATION MARKET: VALUE CHAIN ANALYSIS 89 FIGURE 38 IMAGE-GUIDED NAVIGATION MARKET: SUPPLY CHAIN ANALYSIS 90 FIGURE 39 IMAGE-GUIDED NAVIGATION MARKET: ECOSYSTEM ANALYSIS 91 FIGURE 40 ADJACENT MARKETS FOR IMAGE-GUIDED NAVIGATION MARKET 93 FIGURE 41 IMAGE-GUIDED NAVIGATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 94 FIGURE 42 IMAGE-GUIDED NAVIGATION MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 94 FIGURE 43 IMAGE-GUIDED NAVIGATION MARKET: GEOGRAPHIC SNAPSHOT 159 FIGURE 44 NORTH AMERICA: IMAGE-GUIDED NAVIGATION MARKET SNAPSHOT 161 FIGURE 45 ASIA PACIFIC: IMAGE-GUIDED NAVIGATION MARKET SNAPSHOT 198 FIGURE 46 REVENUE ANALYSIS OF KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET (2020–2024) 254 FIGURE 47 MARKET SHARE ANALYSIS FOR KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET (2024) 255 FIGURE 48 IMAGE-GUIDED NAVIGATION MARKET: COMPANY EVALUATION MATRIX: KEY PLAYERS (2024) 258 FIGURE 49 IMAGE-GUIDED NAVIGATION MARKET: COMPANY FOOTPRINT 259 FIGURE 50 IMAGE-GUIDED NAVIGATION MARKET: COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024) 266 FIGURE 51 EV/EBITDA OF KEY VENDORS 269 FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 269 FIGURE 53 IMAGE-GUIDED NAVIGATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 270 FIGURE 54 R&D ASSESSMENT OF KEY PLAYERS IN IMAGE-GUIDED NAVIGATION MARKET (2022–2024) 271 FIGURE 55 MEDTRONIC: COMPANY SNAPSHOT 276 FIGURE 56 STRYKER: COMPANY SNAPSHOT 285 FIGURE 57 B. BRAUN SE: COMPANY SNAPSHOT 289 FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 293 FIGURE 59 GE HEALTHCARE: COMPANY SNAPSHOT 297 FIGURE 60 OLYMPUS CORPORATION: COMPANY SNAPSHOT 300   FIGURE 61 SMITH+NEPHEW: COMPANY SNAPSHOT 302 FIGURE 62 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 305 FIGURE 63 GLOBUS MEDICAL (NUVASIVE): COMPANY SNAPSHOT 308 FIGURE 64 STEREOTAXIS, INC.: COMPANY SNAPSHOT 310 FIGURE 65 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT 314 FIGURE 66 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 317 FIGURE 67 ZIMMER BIOMET: COMPANY SNAPSHOT 320 FIGURE 68 INTUITIVE SURGICAL: COMPANY SNAPSHOT 322

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們